Skip to main content
Log in

Haemorrhagic Fever Vaccine

  • Section 2: Prophylactic Anti-Infective Vaccines
  • Adis R&D Profile
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Song G, Hang CS, Huang YC, et al. Preliminary trials of inactivated vaccine against haemorrhagic fever with renal syndrome. Lancet 1991 Mar 30; 337 (8744): 801

    Article  PubMed  CAS  Google Scholar 

  2. Maiztegui JI, McKee Jr KT, Barrera Oro JG, et al. Protective efficacy of a live attenuated vaccine against Argentine hemorrhagic fever. J Infect Dis 1998 Feb; 177: 277–83

    Article  PubMed  CAS  Google Scholar 

  3. McKee Jr KT, Barrera Oro JG, Kuehne AI, et al. Safety and immunogenicity of a live-attenuated Junin (Argentine hemorrhagic fever) vaccine in rhesus macaques. Am J Trop Med Hyg 1993 Mar; 48: 403–11

    PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Haemorrhagic Fever Vaccine. Drugs R&D 2, 197–198 (1999). https://doi.org/10.2165/00126839-199902030-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-199902030-00009

Keywords

Navigation